Exchange: NASDAQ·Updated 03:12 AM EDT
XCUR logo

XCUR Exicure Inc

$1.35
$0.05
(3.85%)
Overnight
Prev Close $1.30
Mkt Cap$8.58M
Vol16,728.00

About XCUR

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
59

Bullish Sentiment

How do you feel about XCUR?

Advertisement|Remove ads.